Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of Myc in stem cell biology and novel tumor therapies
Go J. Yoshida
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou, Jun Wang, Jinchun Wu, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 1455
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Jiao Feng, Jingjing Li, Liwei Wu, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 483
Applications of patient-derived tumor xenograft models and tumor organoids
Go J. Yoshida
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 365
MYC protein interactors in gene transcription and cancer
Corey Lourenco, Diana Resetca, Cornelia Redel, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 579-591
Closed Access | Times Cited: 247
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
Go J. Yoshida
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 224
Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
Mohamed Elbadawy, Tatsuya Usui, Hideyuki Yamawaki, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2340-2340
Open Access | Times Cited: 216
Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?
Zahra Ghanbari Movahed, Mohsen Rastegari‐Pouyani, Mohammad Hossein Mohammadi, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 112, pp. 108690-108690
Open Access | Times Cited: 169
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
Jiao Feng, Weiqi Dai, Yuqing Mao, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 168
The roles of glucose metabolic reprogramming in chemo- and radio-resistance
Jinguan Lin, Longzheng Xia, Jiaxin Liang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 149
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
Anshika Goenka, Deanna Tiek, Xiao Song, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 484-484
Open Access | Times Cited: 110
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 61
The ubiquitin–proteasome system in breast cancer
Dianwen Han, Lijuan Wang, Shan Jiang, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 599-621
Closed Access | Times Cited: 47
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Sanjay De Mel, Susan Swee-Shan Hue, Anand D. Jeyasekharan, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 115
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
Faiqa Mudassar, Han Shen, Geraldine M. O’Neill, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 113
miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
Srinivas Chava, C. Patrick Reynolds, Anup Singh Pathania, et al.
Molecular Oncology (2019) Vol. 14, Iss. 1, pp. 180-196
Open Access | Times Cited: 112
Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis
Jiang Yu, Qiuju Han, Huajun Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 98
New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription
Ming-Hao Hu, Tian-Ying Wu, Qiong Huang, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 20, pp. 10529-10542
Open Access | Times Cited: 92
Research progresses in roles of LncRNA and its relationships with breast cancer
Bin Xu, Hongjian Yang, Xiping Zhang, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 89
The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC
Xiaosong Wang, Lei Xing, Rui Yang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 73
Transcriptional factors targeting in cancer stem cells for tumor modulation
Archana Chaudhary, Syed Shadab Raza, Rizwanul Haque
Seminars in Cancer Biology (2023) Vol. 88, pp. 123-137
Open Access | Times Cited: 33
MYC function and regulation in physiological perspective
Rajeev Jha, Fedor Kouzine, David Levens
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 31
The role of hyaluronic acid in the design and functionalization of nanoparticles for the treatment of colorectal cancer
Mariana Carlomagno de Paula, Suzana Gonçalves Carvalho, Amanda Letícia Polli Silvestre, et al.
Carbohydrate Polymers (2023) Vol. 320, pp. 121257-121257
Closed Access | Times Cited: 28
Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?
Ana Helena MAcedo-Pereira, Cláudia Martins, Jorge Lima, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 98-115
Open Access | Times Cited: 27
LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity
Mingming Fei, Xianying Li, Shuhang Liang, et al.
Cancer Letters (2024) Vol. 584, pp. 216620-216620
Open Access | Times Cited: 11
Integrated Bioinformatic Analyses Reveal Thioredoxin as a Putative Marker of Cancer Stem Cells and Prognosis in Prostate Cancer
Shigeru Sugiki, Tetsuhiro Horie, Kenshiro Kunii, et al.
Cancer Informatics (2025) Vol. 24
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top